Cohortias – Mexico and its emerging market for clinical trials.

Mexico offers great benefits for clinical research.
Mexico

Mexico, the best option to carry out your clinical studies

Mexico is fast becoming a major player in the pharmaceutical and medical device industries. It is the number one exporter of medical devices in Latin America and the eighth in the world, as well as a leading exporter of pharmaceutical products in Latin America. It is easy to see why Mexico is the best choice for a clinical research partner.

A brochure describing Mexico’s clinical research capabilities and benefits was recently released.

Mexico
Doctores en la Ciudad De México enfrentando la pandemia de COVID-19

Ideal Patient Population

Mexico has a diverse demographic profile that gives it enormous potential for large-scale patient recruitment. The researchers have experience in all therapeutic areas and population groups (children, adults and older adults) as well as experience in the implementation of a diverse epidemiological profile that includes communicable, non-communicable, chronic-degenerative and rare diseases. IMSS and other national health institutions potentially have access to more than 70% of the country’s diverse patient population.

Regulatory trendsetter

Investigators are trained to the strictest regulatory standards in a framework that establishes criteria for conducting clinical trials in humans. It is a comprehensive regulation that allows the performance of all phases of research and the use of innovative models and designs. In accordance with current regulations, if a clinical research trial includes Mexican patients, Mexico has the option of being the first country in the world to authorize the registration of a molecule. Mexico has more than 120 ethics committees for the approval of research protocols.

Competitive advantages

The Mexican health system offers a range of clinical research alternatives in both the public and private sectors, where health services are highly diversified. They have competitive costs and a high level of specialization in all phases of clinical research. Mexico’s time zone is aligned with the main research centers around the world and the main cities in the region.

Cohortias is the CRO of Mexico and Latin America

With its growing advantages, we encourage sponsors to consider Latin America for clinical research, especially during the early phases of development. Cohortias is committed to the region and has developed the operational infrastructure, regulatory knowledge and site relationships to deliver quality results.

Here are some regional highlights including:

More than 15 years of experience conducting clinical studies in Mexico
Local offices in offices Argentina, Brazil, Mexico and Colombia. (With our own staff, we do not use freelancers)
Access to qualified, trusted, committed and experienced healthcare professionals with culturally stronger patient-physician relationships that make enrollment and compliance easier

Share:

More Posts

Send Us A Message